Edward Samuel

EVP Technical Operations • Achilles Therapeutics

Ed serves as EVP Technical Operations at Achilles with responsibility for overseeing GMP operations for product delivery of its autologous precision T cell therapies, the expansion of the Achilles manufacturing footprint and the integration of automation and device technology driving the future platform for commercial delivery. Ed has over 18 years of industry and academic experience in process development, technology transfer, GMP manufacturing, QC and regulatory affairs in the field of cell and gene therapy. Before joining Achilles in December 2017, Ed was the Cell Therapy Operations Manager for Europe at Orchard Therapeutics where he was responsible for overseeing CDMO tech transfer and establishing the supply-chain infrastructure to support cell therapy manufacturing and regulatory submissions in the US and Europe. Previously, Ed held positions at Cognate BioServices Ltd as Director for Manufacturing and in post-doctoral translational research at University College London (UCL). Ed holds a PhD in T cell Immunology from UCL, and an MSc in Medical Immunology from King’s College London.

Also speaking

Mark Kotter

Founder • Bit Bio

Sofia Hakansson Buch

Vice President for Cell Therapy CMC • Novo Nordisk

Shree Patel

EVP Patient Supply Operations • Achilles Therapeutics

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.